| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.053 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |